SR-1078是一种选择性的类视黄酸受体相关孤儿受体α/γ(RORα/RORγ)激动剂。它直接结合RORα和RORγ的配体结合域,增加它们的转录活性,并刺激RORα/γ靶基因的转录。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} {[ size_append(item.pr_size_append, item.pr_am, item.pr_size) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | SR1078 is a selective agonist of the retinoic acid receptor-related orphan receptors α and γ (RORα/RORγ). It binds directly to the ligand-binding domain of RORα and RORγ, enhancing their transcriptional activity and thereby stimulating the transcription of RORα/γ target genes[1][2]. |
| 体内研究 | Pharmacokinetic studies of SR1078 in mice reveal significant exposure levels. After a single 10 mg/kg intraperitoneal injection, plasma concentrations reach 3.6 µM within 1 hour and maintain levels above 800 nM for up to 8 hours, validating the compound's efficacy for in vivo gene expression studies. Two hours post-injection, SR1078 significantly stimulates the expression of G6Pase and FGF21 genes in the liver[1]. SR1078 administered at a dose of 10 mg/kg intraperitoneally leads to a significant 25% reduction in repetitive grooming behavior in BTBR mice[2]. |
| 体外研究 | SR1078, a synthetic ligand for RORα/RORγ, alters the conformation of RORγ in biochemical assays and activates transcription driven by RORα and RORγ. SR1078 also boosts the expression of endogenous ROR target genes in HepG2 cells expressing these receptors. In cell-based assays using a chimeric receptor with the Gal4 DNA-binding domain and NR ligand-binding domain, SR1078 significantly diminishes the constitutive transactivation activities of RORα and RORγ, while not affecting FXR, LXRα, and LXRβ activities. Treatments with SR1078 at 10 µM notably enhance transcriptional activity in RORα and RORγ cotransfection assays[1]. SR1078 administered at concentrations between 2-10 µM over 24 hours results in a dose-dependent increase in the expression of genes such as A2BP1, CYP19A1, NLGN1, and IPTR1 in SH-SY5Y cells, with EC50s around 3-5 µM[2]. |
| 作用机制 | SR1078 plays its role by directly binding to the ligand binding domain of RORα and RORγ and increases the transcriptional activity of these receptors, leading to stimulation of RORα/γ target gene transcription. |
| Concentration | Treated Time | Description | References | |
| MYCN3 cells | 5 µM | 24 hours | Restoration of BMAL1 mRNA and protein levels | Nat Commun. 2021 Jun 28;12(1):4006. |
| SK-N-BE(2)-C cells | 10 µM | 24 hours | Activation of RORα target genes (G6Pase, FGF-21, and BMAL1) transcription | Nat Commun. 2021 Jun 28;12(1):4006. |
| LAN5 cells | 10 µM | 24 hours | Activation of RORα target genes (G6Pase, FGF-21, and BMAL1) transcription | Nat Commun. 2021 Jun 28;12(1):4006. |
| HEK293 cells | 10 µM | 24 hours | To assess the potential activity of SR1078 on RORβ. Results showed that SR1078 had no activity on RORβ at 10 μM but significantly enhanced the activity of RORα and RORγ. | ACS Chem Neurosci. 2016 Feb 17;7(2):143-8. |
| SH-SY5Y cells | 2, 4, 6, 8, 10 µM | 24 hours | To evaluate the effect of SR1078 on the expression of ASD-associated genes. Results showed that SR1078 dose-dependently increased the expression of A2BP1, CYP19A1, NLGN1, and IPTR1, with EC50s in the range of 3-5 μM. | ACS Chem Neurosci. 2016 Feb 17;7(2):143-8. |
| HepG2 cells | 10 µM | 24 hours | SR1078 treatment resulted in a significant 3-fold increase in FGF21 mRNA expression. G6Pase mRNA expression was also significantly stimulated ~2-fold by SR1078 treatment. | ACS Chem Biol. 2010 Nov 19;5(11):1029-34. |
| HEK293 cells | 10 µM | 24 hours | SR1078 significantly inhibited the constitutive transactivation activity of ROR α and ROR γ, but had no effect on the activity of FXR, LXR α and LXR β. | ACS Chem Biol. 2010 Nov 19;5(11):1029-34. |
| SK-N-AS MYCN-ER cells | 5 µM | 72 hours | Inhibition of MYCN-mediated lipid metabolism | Nat Commun. 2021 Jun 28;12(1):4006. |
| Human chondrocytes | 1 µM | 48 hours | SR1078 treatment led to decreased expression of COL2A1 and SOX9, and promoted the expression of MMP13, ADAMTS4, and ADAMTS5 | Cell Death Dis. 2021 Sep 28;12(10):886. |
| Huh7 cells | 10 µM | Overnight | To test the effect of SR1078 on MIR122 promoter activity, it was found that SR1078 could induce MIR122 promoter activity. | Gastroenterology. 2020 Sep;159(3):999-1014.e9. |
| Administration | Dosage | Frequency | Description | References | ||
| BTBR mice | Autism model | Intraperitoneal injection | 10 mg/kg | Once daily for two weeks | To evaluate the effect of SR1078 on behavior in an autism model. Results showed that SR1078 significantly reduced repetitive grooming behavior in BTBR mice (25% reduction) and increased the expression of ASD-associated genes. | ACS Chem Neurosci. 2016 Feb 17;7(2):143-8. |
| Mice | C57BL6 mice | Intraperitoneal injection | 10 mg/kg | Single injection | SR1078 treatment significantly stimulated the expression of FGF21 and G6Pase in the liver. | ACS Chem Biol. 2010 Nov 19;5(11):1029-34. |
| Nude mice | LAN5 cell xenograft model | Intraperitoneal injection | 15 mg/kg | Once daily for 14 days | Significant inhibition of tumor growth and restoration of BMAL1 protein levels | Nat Commun. 2021 Jun 28;12(1):4006. |
| C57BL/6 mice | High-fat diet-induced fatty liver model | Intraperitoneal injection | 7.5 mg/kg | Twice a week for 3 weeks | To evaluate the therapeutic effect of RS-2982 on fatty liver, the results showed that RS-2982 significantly reduced hepatic steatosis, inflammation, and fibrosis, and improved insulin resistance and weight gain. | Gastroenterology. 2020 Sep;159(3):999-1014.e9. |
| Dose | Mice: 10 mg/kg[3] (i.p.); 100 mg/kg - 500 mg/kg (p.o.) |
| Administration | i.p., p.o. |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.32mL 0.46mL 0.23mL |
11.59mL 2.32mL 1.16mL |
23.19mL 4.64mL 2.32mL |
|
| CAS号 | 1246525-60-9 |
| 分子式 | C17H10F9NO2 |
| 分子量 | 431.25 |
| SMILES Code | O=C(NC1=CC=C(C(C(F)(F)F)(C(F)(F)F)O)C=C1)C2=CC=C(C(F)(F)F)C=C2 |
| MDL No. | MFCD18782737 |
| 别名 | |
| 运输 | 蓝冰 |
| InChI Key | DUXWIYXHHGNUJU-UHFFFAOYSA-N |
| Pubchem ID | 17980288 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, store in freezer, under -20°C |
| 溶解方案 |
DMSO: 35 mg/mL(81.16 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1